Safety and efficacy of intensive vs. guideline antiplatelet therapy in high-risk patients with recent ischemic stroke or transient ischemic attack: rationale and design of the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARDIS) trial (ISRCTN47823388)

Safety and efficacy of intensive vs. guideline antiplatelet therapy in high-risk patients with recent ischemic stroke or transient ischemic attack: rationale and design of the Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke (TARDIS) trial (ISRCTN47823388)

RATIONALE: The risk of recurrence following a stroke or transient ischemic attack is high, especially immediately after the event. HYPOTHESIS: Because two antiplatelet agents are superior to one in patients with non-cardioembolic events, more intensive treatment might be even more effective....

Full description

Bibliographic Details
Main Authors: Beridze, M., Christensen, H., Dineen, Robert A., Duley, Lelia, Heptinstall, Stan, James, M., Markus, H.S., Pocock, S, Ranta, A., Robinson, T., Nikola, N., Venables, G., Bath, Philip M.W.
Format: Article
Published: Wiley 2015
Subjects:
acute stroke
aspirin
clopidogrel
dipyridamole
randomized controlled trial
transient ischemic attack
Online Access:https://eprints.nottingham.ac.uk/37716/

Internet

https://eprints.nottingham.ac.uk/37716/

Similar Items